Tick-Transmitted Diseases in Dogs: Lyme Disease, Ehrlichiosis, Anaplasmosis, and Babesiosis

Introduction

Tick-transmitted diseases represent a significant and growing burden in canine medicine globally. The geographic expansion of tick vectors, driven by climate change and habitat alteration, has increased the exposure of domestic dogs to a complex array of bacterial and protozoan pathogens [1]. The four most clinically relevant tick-transmitted diseases in dogs are Lyme disease (borreliosis), ehrlichiosis, anaplasmosis, and babesiosis. Each disease is caused by distinct pathogens with unique life cycles, vector associations, and pathophysiological mechanisms. Understanding the biological, chemical, and physical interactions between the pathogen, the tick vector, and the canine host is essential for accurate diagnosis, effective treatment, and rational prevention. This article provides a detailed, publication-grade review of these four diseases, focusing on etiology, epidemiology, clinical signs, pathology, diagnostic methodologies, therapeutic protocols, and preventive strategies. For a broader overview of related conditions, readers may consult the article on Tick-Transmitted Diseases in Dogs: Pathogens, Clinical Syndromes, and Management.

Etiology and Pathogen Biology

Lyme Disease (Canine Borreliosis)

Lyme disease in dogs is caused by the spirochete bacterium Borrelia burgdorferi sensu stricto, a member of the Borrelia burgdorferi sensu lato complex [2]. This microaerophilic, motile spirochete is approximately 20 to 30 micrometers in length and 0.2 to 0.3 micrometers in diameter [2]. The outer membrane contains abundant lipoproteins, including outer surface proteins (Osps) such as OspA, OspC, and OspF, which are critical for host infection and immune evasion [3]. B. burgdorferi lacks lipopolysaccharide and relies on a highly reduced genome for its parasitic lifestyle [2]. The primary tick vector in North America is Ixodes scapularis (the black-legged tick), while Ixodes ricinus serves as the principal vector in Europe [1, 3]. Transmission occurs after the tick has been attached for at least 24 to 48 hours, as the spirochetes must migrate from the tick midgut to the salivary glands [3].

Ehrlichiosis

Canine ehrlichiosis is primarily caused by the obligate intracellular Gram-negative bacterium Ehrlichia canis, which targets mononuclear phagocytes [4]. E. canis is a member of the family Anaplasmataceae and resides within membrane-bound vacuoles (morulae) in monocytes and macrophages [4]. The bacterium has a biphasic developmental cycle consisting of elementary bodies (infectious form) and reticulate bodies (replicative form) [4]. The principal tick vector is Rhipicephalus sanguineus (the brown dog tick), which is adapted to indoor and kennel environments [5]. Other species, such as Ehrlichia ewingii, infect granulocytes and are transmitted by Amblyomma americanum (the lone star tick) [5].

Anaplasmosis

Canine anaplasmosis is caused by two distinct species: Anaplasma phagocytophilum and Anaplasma platys [6]. A. phagocytophilum is an obligate intracellular bacterium that infects neutrophils and forms morulae within these cells [6]. It is transmitted primarily by Ixodes scapularis and Ixodes pacificus in North America [6]. A. platys is a thrombocytotropic bacterium that infects platelets, causing infectious cyclic thrombocytopenia [7]. The vector for A. platys is less definitively established but is believed to involve Rhipicephalus sanguineus [7]. Both species are members of the family Anaplasmataceae and share antigenic cross-reactivity with Ehrlichia species [6].

Babesiosis

Canine babesiosis is caused by protozoan parasites of the genus Babesia, which are intraerythrocytic apicomplexans [8]. The two major species are Babesia canis (large form, approximately 4 to 5 micrometers) and Babesia gibsoni (small form, approximately 1 to 3 micrometers) [8]. B. canis is transmitted by Dermacentor reticulatus and Rhipicephalus sanguineus ticks, while B. gibsoni is often associated with Rhipicephalus sanguineus and also has a significant direct transmission route through dog bites and blood transfusion [8, 9]. The parasite undergoes sexual reproduction in the tick vector and asexual multiplication (merogony) within canine erythrocytes [8]. Hemolysis results from both direct parasite-mediated damage and immune-mediated destruction of infected and uninfected red blood cells [9].

Epidemiology and Vector Ecology

The epidemiology of dog tick transmitted diseases is intrinsically linked to the geographic distribution and seasonal activity of tick vectors. Ixodes scapularis is endemic in the northeastern, mid-Atlantic, and upper midwestern United States, as well as parts of Canada [1]. Rhipicephalus sanguineus has a cosmopolitan distribution and is found in both tropical and temperate climates, often infesting kennels and homes [5]. Dermacentor variabilis (the American dog tick) and Amblyomma americanum also transmit certain pathogens, though their roles in the diseases discussed here are secondary [1].

Co-infections with multiple tick-borne pathogens are common in endemic areas, as a single tick may harbor more than one organism and dogs are frequently exposed to multiple tick bites [10]. Seroprevalence rates for B. burgdorferi in endemic regions of the United States can exceed 10% in dogs, while E. canis seroprevalence in tropical regions may reach 30% or higher [1, 5]. A. phagocytophilum seroprevalence mirrors that of Lyme disease due to shared vector ecology [6]. Babesia species prevalence varies widely, with B. gibsoni being particularly common in fighting dog breeds and kennel environments [9].

Clinical Signs and Pathophysiology

Lyme Disease

The majority of dogs infected with B. burgdorferi remain subclinical [2]. Clinical disease manifests as acute-onset lameness due to immune-mediated polyarthritis, often shifting between limbs [2]. Fever, lethargy, and lymphadenomegaly are common [2]. Renal involvement, termed Lyme nephritis, is a severe and often fatal complication characterized by protein-losing nephropathy with glomerulonephritis and interstitial nephritis [3]. The pathophysiology involves immune complex deposition in synovial membranes and renal glomeruli, triggering complement activation and neutrophilic inflammation [3]. Neurologic signs (e.g., facial nerve paralysis) and cardiac abnormalities (e.g., myocarditis) are rare in dogs compared to humans [2].

Ehrlichiosis

Canine ehrlichiosis presents in three phases: acute, subclinical, and chronic [4]. The acute phase, occurring 1 to 3 weeks post-infection, is characterized by fever, depression, anorexia, lymphadenomegaly, splenomegaly, and thrombocytopenia [4]. The subclinical phase may persist for months to years, with the dog appearing healthy but harboring the organism in the spleen and bone marrow [4]. The chronic phase, most commonly seen in E. canis infection, involves severe pancytopenia, epistaxis, petechiation, and secondary infections due to bone marrow hypoplasia [4]. The pathophysiology is driven by the infection of mononuclear phagocytes, leading to immune-mediated destruction of platelets and suppression of hematopoietic progenitor cells [4, 5].

Anaplasmosis

Anaplasma phagocytophilum infection typically causes an acute febrile illness with lethargy, anorexia, and lameness due to polyarthritis [6]. Thrombocytopenia is a consistent laboratory finding [6]. Neurologic signs, such as ataxia and seizures, are occasionally reported [6]. A. platys infection is characterized by cyclic thrombocytopenia, with platelet counts dropping every 10 to 14 days [7]. Most dogs with A. platys are asymptomatic, but severe thrombocytopenia can lead to petechiation and epistaxis [7]. The pathophysiology of A. phagocytophilum involves neutrophil dysfunction, impaired phagocytosis, and immune-mediated platelet destruction [6].

Babesiosis

Canine babesiosis ranges from subclinical infection to severe, life-threatening hemolytic anemia [8]. Clinical signs include fever, lethargy, pale mucous membranes, hemoglobinuria, and splenomegaly [8]. B. canis infections tend to be more severe in naive adult dogs, while B. gibsoni often causes chronic, low-grade anemia [9]. Complications include disseminated intravascular coagulation, acute kidney injury, hepatopathy, and cerebral babesiosis (due to erythrocyte sequestration in cerebral capillaries) [9]. The pathophysiology involves direct erythrocyte lysis during parasite egress, oxidative damage to red cell membranes, and immune-mediated hemolysis [8, 9].

Diagnostic Approaches

Diagnosis of tick-transmitted diseases in dogs relies on a combination of signalment, history, physical examination, hematology, serology, and molecular testing. A diagnostic decision tree is presented below.

flowchart TD
    A[Clinical Suspicion: Fever, Lameness, Thrombocytopenia, Anemia], > B{Point-of-Care SNAP Test}
    B, >|Positive for B. burgdorferi| C[Lyme Disease: Confirm with C6 antibody ELISA +/- PCR]
    B, >|Positive for E. canis or A. phagocytophilum| D[Ehrlichiosis/Anaplasmosis: Species-specific PCR]
    B, >|Negative| E{Blood Smear Examination}
    E, >|Morulae in Monocytes| F[Ehrlichiosis: PCR for E. canis]
    E, >|Morulae in Neutrophils| G[Anaplasmosis: PCR for A. phagocytophilum]
    E, >|Intraerythrocytic Parasites| H[Babesiosis: PCR for Babesia spp.]
    E, >|No Visible Pathogens| I[Consider PCR Panel for All Pathogens]
    C, > J[Treatment: Doxycycline 10 mg/kg q24h x 30 days]
    D, > J
    G, > J
    F, > J
    H, > K[Treatment: Atovaquone + Azithromycin or Imidocarb]
    I, > L[Re-evaluate: Repeat Serology in 2-4 Weeks]

Hematology and Blood Smear Microscopy

Complete blood count (CBC) using automated impedance analyzers frequently reveals thrombocytopenia in ehrlichiosis, anaplasmosis, and babesiosis [4, 6, 8]. Anemia is characteristic of babesiosis and chronic ehrlichiosis [8]. Manual examination of Giemsa-stained or Wright-stained blood smears can identify morulae in monocytes (E. canis), neutrophils (A. phagocytophilum), or platelets (A. platys) [4, 6, 7]. Intraerythrocytic parasites are diagnostic for babesiosis, with B. canis appearing as large pear-shaped merozoites and B. gibsoni as small ring forms [8]. Sensitivity of blood smear examination is low, particularly in chronic or low-parasitemia infections [8].

Serology

In-clinic enzyme-linked immunosorbent assays (ELISAs) that detect antibodies against B. burgdorferi C6 peptide, E. canis, and A. phagocytophilum are widely used [2, 4, 6]. The C6 peptide assay is specific for B. burgdorferi infection and does not cross-react with vaccination [2]. Indirect immunofluorescence assays (IFAs) remain the reference standard for quantitative serology, with a four-fold rise in titer between acute and convalescent samples indicating active infection [4, 6]. Serology for Babesia species is available but cross-reactivity between species complicates interpretation [8].

Molecular Diagnostics

Polymerase chain reaction (PCR) assays targeting species-specific genes (e.g., p30 for E. canis, msp2 for A. phagocytophilum, 18S rRNA for Babesia spp.) offer high sensitivity and specificity [4, 6, 8]. Real-time PCR allows quantification of pathogen load, which can be useful for monitoring treatment response [8]. PCR is particularly valuable for detecting acute infections before seroconversion and for confirming active infection in seropositive dogs [4]. High-throughput sequencing platforms can identify co-infections and novel pathogens in research settings [10].

Treatment Protocols

Lyme Disease

The recommended treatment for canine Lyme disease is doxycycline at 10 mg/kg orally every 24 hours for 30 days [2]. Amoxicillin or cefovecin are alternative options [2]. Clinical signs typically resolve within 24 to 48 hours of therapy initiation [2]. Dogs with Lyme nephritis require aggressive supportive care including intravenous fluids, angiotensin-converting enzyme inhibitors, and immunosuppressive doses of corticosteroids [3]. Despite therapy, the prognosis for Lyme nephritis is guarded to poor [3].

Ehrlichiosis and Anaplasmosis

Doxycycline at 10 mg/kg orally every 24 hours for 28 days is the treatment of choice for both ehrlichiosis and anaplasmosis [4, 6]. Clinical improvement is usually rapid, but thrombocytopenia may persist for weeks [4]. For dogs with severe pancytopenia due to chronic ehrlichiosis, supportive care including blood transfusions and broad-spectrum antibiotics for secondary infections is necessary [4]. Relapses can occur, particularly in E. canis infections, and retreatment with a longer course of doxycycline may be required [5].

Babesiosis

Treatment of canine babesiosis depends on the species involved. For B. canis, imidocarb dipropionate at 5 to 6.6 mg/kg intramuscularly or subcutaneously, repeated once after 14 days, is effective [8]. For B. gibsoni, a combination of atovaquone (13.5 mg/kg orally every 8 hours) and azithromycin (10 mg/kg orally every 24 hours) for 10 days is recommended [9]. This combination has shown superior efficacy compared to imidocarb alone for B. gibsoni [9]. Supportive care includes intravenous fluids, blood transfusions for severe anemia, and corticosteroids for immune-mediated hemolysis [8]. Dogs that remain PCR-positive after treatment may require a second course of therapy [9].

Prevention and Vector Control

Prevention of dog tick transmitted diseases relies on three pillars: vector control, vaccination, and environmental management.

Acaricide Use

Monthly administration of acaricides in the form of topical spot-ons, oral chewables, or collars is the cornerstone of prevention [1]. Isoxazoline compounds (e.g., afoxolaner, fluralaner, sarolaner) provide rapid tick kill and sustained protection for 4 to 12 weeks [1]. Pyrethroid-based collars (e.g., flumethrin) offer extended protection for up to 8 months [1]. For detailed guidance on product selection, refer to the article on Best Flea And Tick Prevention For Dogs.

Vaccination

A commercial bacterin vaccine for B. burgdorferi is available for dogs [2]. The vaccine targets OspA and OspC and induces antibodies that kill spirochetes in the tick midgut upon feeding [2]. Vaccination does not prevent infection but reduces the risk of clinical disease and seroconversion [2]. No vaccines are currently licensed for ehrlichiosis, anaplasmosis, or babesiosis [4, 6, 8].

Environmental Management

Reducing tick habitat around the home, including leaf litter removal, grass mowing, and the use of environmental acaricides, decreases tick exposure [1]. Dogs should be inspected for ticks after outdoor activity, and attached ticks should be removed promptly with fine-tipped forceps [1].

Prognosis and Long-Term Management

The prognosis for dogs with Lyme disease, anaplasmosis, and acute ehrlichiosis is excellent with appropriate antibiotic therapy [2, 4, 6]. Chronic ehrlichiosis and babesiosis carry a more guarded prognosis, particularly in cases with severe bone marrow suppression or hemolytic crisis [4, 8]. Dogs that recover from babesiosis may remain subclinically infected and serve as reservoirs for tick transmission [9]. Long-term monitoring with periodic CBC and PCR testing is recommended for dogs with a history of these infections [4, 8].

Conclusion

Tick-transmitted diseases in dogs, including Lyme disease, ehrlichiosis, anaplasmosis, and babesiosis, are complex, vector-borne infections with significant clinical and diagnostic challenges. A thorough understanding of pathogen biology, vector ecology, and host-pathogen interactions is essential for veterinary practitioners. Advances in serological and molecular diagnostics have improved the ability to detect and differentiate these infections. Effective treatment protocols exist for all four diseases, but prevention through rigorous tick control remains the most effective strategy. As tick ranges continue to expand, the importance of integrated tick management and client education cannot be overstated.

References

[1] Little SE, Beall MJ, Bowman DD, Chandrashekar R, Stamaris J. Canine infection with Dirofilaria immitis, Borrelia burgdorferi, Anaplasma spp., and Ehrlichia spp. in the United States, 2010-2012. Parasit Vectors. 2014;7:257.

[2] Littman MP, Gerber B, Goldstein RE, Labato MA, Lappin MR, Moore GE. ACVIM consensus update on Lyme borreliosis in dogs and cats. J Vet Intern Med. 2018;32(3):887-903.

[3] Dambach DM, Smith CA, Lewis RM, Van Winkle TJ. Morphologic, immunohistochemical, and ultrastructural characterization of a distinctive renal lesion in dogs putatively associated with Borrelia burgdorferi infection: 49 cases (1987-1992). Vet Pathol. 1997;34(2):85-96.

[4] Neer TM, Breitschwerdt EB, Greene RT, Lappin MR. Consensus statement on ehrlichial disease of dogs from the infectious disease study group of the ACVIM. J Vet Intern Med. 2002;16(3):309-315.

[5] Harrus S, Waner T. Diagnosis of canine monocytotropic ehrlichiosis (Ehrlichia canis): an overview. Vet J. 2011;187(3):292-296.

[6] Carrade DD, Foley JE, Borjesson DL, Sykes JE. Canine granulocytic anaplasmosis: a review. J Vet Intern Med. 2009;23(6):1129-1141.

[7] Harvey JW, Simpson CF, Gaskin JM. Cyclic thrombocytopenia induced by a rickettsia-like agent in dogs. J Infect Dis. 1978;137(2):182-188.

[8] Irwin PJ. Canine babesiosis: from molecular taxonomy to control. Parasit Vectors. 2009;2(Suppl 1):S4.

[9] Birkenheuer AJ, Levy MG, Breitschwerdt EB. Development and evaluation of a seminested PCR for detection and differentiation of Babesia gibsoni (Asian genotype) and B. canis DNA in canine blood samples. J Clin Microbiol. 2003;41(9):4172-4177.

[10] Yabsley MJ, Wimberly MC, Stallknecht DE, Little SE. Spatial analysis of the distribution of Ehrlichia chaffeensis and Ehrlichia ewingii in the United States. Emerg Infect Dis. 2003;9(12):1576-1582. *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.